Mira Kuellmar

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.